Director/PDMR Shareholding

RNS Number : 3232F

GlaxoSmithKline PLC

19 February 2018

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr N Hirons
b)	Position/status	SVP, Global Ethics & Compliance
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	GlaxoSmithKline plc American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature of the transaction	The lapse of options over 4,600 ADSs, granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan, at an option price of $44.75.
c)	Price(s) and volume(s)	Price(s) Volume(s) n/a 2,366 (Incentive Stock Option) n/a 2,234 (Non-Qualified Stock Option)
d)	Aggregated information   Aggregated volume Price	4,600 n/a
e)	Date of the transaction	2018-02-19
f)	Place of the transaction	n/a

 

END

 

 

DSHVKLFFVLFFBBB